PT  - JOURNAL ARTICLE
AU  - Conor Owens-Walton
AU  - David Jakabek
AU  - Brian D. Power
AU  - Mark Walterfang
AU  - Sara Hall
AU  - Danielle van Westen
AU  - Jeffrey C.L. Looi
AU  - Marnie Shaw
AU  - Oskar Hansson
TI  - Neuroimaging biomarkers differentiate Parkinson disease with and without cognitive impairment and dementia
AID  - 10.1101/19002147
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 19002147
4099  - http://medrxiv.org/content/early/2019/08/26/19002147.short
4100  - http://medrxiv.org/content/early/2019/08/26/19002147.full
AB  - Mild cognitive impairment in Parkinson disease places a high burden on patients and is likely a precursor to Parkinson disease-related dementia. Studying the functional connectivity and morphology of subcortical structures within basal ganglia-thalamocortical circuits may uncover neuroimaging biomarkers of cognitive dysfunction in PD. We used an atlas-based seed region-of-interest approach to investigate resting-state functional connectivity of important subdivisions of the caudate nucleus, putamen and thalamus, between controls (n = 33), cognitively unimpaired Parkinson disease subjects (n = 33), Parkinson disease subjects with mild cognitive impairment (n = 22) and Parkinson disease subjects with dementia (n = 17). We then investigated how the morphology of the caudate, putamen and thalamus structures and differed between groups. Results indicate that cognitively unimpaired Parkinson disease subjects, compared to controls, display increased functional connectivity of the dorsal caudate, anterior putamen and mediodorsal thalamic subdivisions with areas across the frontal lobe, as well as reduced functional connectivity of the dorsal caudate with posterior cortical and cerebellar regions. Compared to cognitively unimpaired subjects, Parkinson disease subjects with mild cognitive impairment demonstrated reduced functional connectivity of the mediodorsal thalamus with midline nodes within the executive-control network. Compared to subjects with mild cognitive impairment, subjects with dementia demonstrated reduced functional connectivity of the mediodorsal thalamus with the posterior cingulate cortex, a key node within the default-mode network. Extensive volumetric and surface-based deflation was found in Parkinson disease subjects with dementia. Our research demonstrates how functional connectivity of the caudate, putamen and thalamus are implicated in the pathophysiology of cognitive impairment and dementia in Parkinson disease, with mild cognitive impairment and dementia in Parkinson disease associated with a breakdown in functional connectivity of the mediodorsal thalamus with para- and posterior cingulate regions of the brain.Competing Interest StatementOH has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Biogen and Roche.Funding StatementCO-W would like to acknowledge the Australian National University for their funding support via the University Research Scholarship. Work at the authors' research center was supported by the European Research Council, the Swedish Research Council, the Knut and Alice Wallenberg foundation, the Marianne and Marcus Wallenberg foundation, the Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University, the Swedish Alzheimer Foundation, the Swedish Brain Foundation, The Parkinson foundation of Sweden, The Parkinson Research Foundation, the Skåne University Hospital Foundation, and the Swedish federal government under the ALF agreement. DJ reports no funding sources. MW has received consulting fees and honoraria from Actelion Pharmaceuticals and receives royalties from ACER (Australian Council of Educational research) for the NUCOG, a pencil and paper cognitive assessment tool (not used in this study). Funding sources had no role in the design and conduct of the study, in the collection, analysis, interpretation of the data or in the preparation, review or approval of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesAnonymized data will be shared by request from any qualified investigator for the sole purpose of replicating procedures and results presented in the article and as long as data transfer is in agreement with EU legislation on the general data protection regulation. Data underlying the results described in our manuscript are available from at Attention: Conor Owens-Walton Academic Unit of Psychiatry & Addiction Medicine Australian National University Medical School Building 4, Level 2, Canberra Hospital Woden, A.C.T. 2605 AUSTRALIA or (conor.owens-walton@anu.edu.au)